Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Teladoc Health Yönetim
Yönetim kriter kontrolleri 2/4
Şu anda CEO hakkında yeterli bilgiye sahip değiliz.
Anahtar bilgiler
Chuck Divita
İcra Kurulu Başkanı
n/a
Toplam tazminat
| CEO maaş yüzdesi | n/a |
| CEO görev süresi | less than a year |
| CEO sahipliği | n/a |
| Yönetim ortalama görev süresi | 7yrs |
| Yönetim Kurulu ortalama görev süresi | 6yrs |
Son yönetim güncellemeleri
Recent updates
Teladoc Health, Inc. (NYSE:TDOC) Surges 28% Yet Its Low P/S Is No Reason For Excitement
Sep 18
Teladoc Health: Some Negative Things, But One Aspect That Makes Me Feel Positive
Sep 15Teladoc: Prospects Are Ready For Better Health
Sep 04Teladoc Post Q2 Earnings: Stick A Fork In This Stock - It's Nearly Done (For)
Aug 01Teladoc's Vital Signs: Why 5x FCF Means Stable Health (Rating Upgrade)
Jul 22Teladoc Health, Inc.'s (NYSE:TDOC) Revenues Are Not Doing Enough For Some Investors
Jul 17Teladoc Health: Weight Loss Management Could Help
Jul 01Would Teladoc Health (NYSE:TDOC) Be Better Off With Less Debt?
Jun 04Teladoc: Stock Likely To Be Range Bound Until Guidance Is Revised Upwards
May 31Teladoc: Huge Execution Problem
Apr 27Teladoc: Improving Business Trends (Rating Upgrade)
Apr 17Teladoc: Management Has A Lot To Prove To Gain Investor Confidence
Mar 25Teladoc Health, Inc.'s (NYSE:TDOC) 25% Dip In Price Shows Sentiment Is Matching Revenues
Mar 10Teladoc Health: Another Bad Quarter, Another Wave Of Capitulation
Feb 21Teladoc Health: Weight Management Rescue
Jan 21Teladoc Health (NYSE:TDOC) Is Carrying A Fair Bit Of Debt
Jan 15When Should You Buy Teladoc Health, Inc. (NYSE:TDOC)?
Dec 12Teladoc Q3: Getting Stronger (Rating Upgrade)
Nov 29Teladoc Health, Inc.'s (NYSE:TDOC) Intrinsic Value Is Potentially 78% Above Its Share Price
Nov 22Teladoc Was Obliterated
Oct 25Is Teladoc Health (NYSE:TDOC) A Risky Investment?
Oct 11Teladoc: Broken Growth Story Deteriorates Further (Rating Downgrade)
Oct 02Teladoc Stock: A Hold Amid New Covid Wave
Sep 14Teladoc's Technical Decline Hints At A Buying Opportunity
Aug 28Is There An Opportunity With Teladoc Health, Inc.'s (NYSE:TDOC) 44% Undervaluation?
Aug 18Buy Teladoc: AI Will Likely Spur Healthcare Deflation
Aug 16Teladoc's Future: Virtual Healthcare, AI, And Valuation
Jul 28Teladoc And Microsoft's Expanded Strategic Partnership Is A Powerful AI Combo
Jul 21The Big Trends: New Frontiers in Healthcare
Jul 13
When Should You Buy Teladoc Health, Inc. (NYSE:TDOC)?
Jul 10Teladoc Health: Likely To Remain Out Of Favor
Jun 26Teladoc Health, Inc.'s (NYSE:TDOC) Revenues Are Not Doing Enough For Some Investors
Jun 25Here's Why Teladoc Health (NYSE:TDOC) Can Afford Some Debt
May 25Teladoc: BetterHelp Segment Margins Are Key
May 23Are Investors Undervaluing Teladoc Health, Inc. (NYSE:TDOC) By 20%?
May 06Is It Too Late To Consider Buying Teladoc Health, Inc. (NYSE:TDOC)?
Mar 10Teladoc Health Non-GAAP EPS of -$0.23 misses by $0.04, revenue of $637.7M beats by $4.33M
Feb 22Is Teladoc Health (NYSE:TDOC) Using Too Much Debt?
Feb 01Teladoc's Stock Is Showing Signs Of Life
Jan 30Teladoc: Unrealistic Assumptions Required To Buy
Jan 09Teladoc: A Bargain If It Ever Reaches GAAP Profitability
Jan 02An Intrinsic Calculation For Teladoc Health, Inc. (NYSE:TDOC) Suggests It's 45% Undervalued
Dec 23Why did Teladoc Health stock fall today? Continued pressure for telehealth providers
Dec 22Teladoc: Death By A Thousand Paper Cuts
Dec 17CEO
Chuck Divita (54 yo)
less than a year
Görev süresi
Mr. Charles Divita, III is CEO and Director at Teladoc Health, Inc. since June 2024. He served as Florida Combined Life Insurance Company, Inc. from 2018 to 2024. He had been Executive Vice President of Co...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Chief Financial Officer | 5.3yrs | US$5.94m | 0.050% $ 775.3k | |
| Chief Operating Officer | 2.3yrs | US$4.80m | 0.046% $ 708.0k | |
| Chief Legal Officer & Secretary | 9.7yrs | US$3.54m | 0.027% $ 418.1k | |
| CEO & Director | less than a year | Veri yok | Veri yok | |
| Co-Founder | 22.8yrs | Veri yok | Veri yok | |
| Senior VP & Chief Accounting Officer | less than a year | Veri yok | Veri yok | |
| Chief Technology Officer | no data | Veri yok | 0.044% $ 681.7k | |
| Vice President of Investor Relations | no data | Veri yok | Veri yok | |
| Executive Vice President of Corporate Development | 9.8yrs | US$2.07m | 0.012% $ 187.7k | |
| Chief Marketing Officer & Engagement Officer | 8.8yrs | US$2.01m | 0.029% $ 441.6k | |
| Chief People Officer | 4yrs | Veri yok | 0.026% $ 406.0k | |
| Chief Strategy Officer | 9.8yrs | Veri yok | 0.018% $ 284.5k |
7.0yrs
Ortalama Görev Süresi
53yo
Ortalama Yaş
Deneyimli Yönetim: TDOC 'un yönetim ekibi deneyimli ve deneyimlidir ( 7 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| CEO & Director | less than a year | Veri yok | Veri yok | |
| Independent Director | 14.9yrs | US$290.00k | 0.023% $ 353.2k | |
| Independent Director | 8.1yrs | US$294.49k | 0.0086% $ 133.9k | |
| Independent Non-Executive Chairman | 10.7yrs | US$332.50k | 0.069% $ 1.1m | |
| Independent Director | 3.9yrs | US$280.00k | 0.024% $ 365.4k | |
| Independent Director | 7.7yrs | US$285.00k | 0% $ 0 | |
| Independent Director | 6yrs | US$283.00k | 0.0049% $ 75.5k | |
| Independent Director | 4.7yrs | US$280.00k | 0.012% $ 184.3k | |
| Independent Director | 1.1yrs | US$264.69k | 0.0024% $ 36.7k |
6.0yrs
Ortalama Görev Süresi
69yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: TDOC 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6 yıldır).